FDA chief gives promises on generics

Citing the saving of $1.67 trillion that competition from generics has brought to the US health care system in the last decade, Food and Drug Administration (FDA) Commissioner Scott Gottlieb has voiced his support for more of these copycat drugs to reach market sooner.

Dr Gottlieb pledged to help make this happen by addressing scientific and regulatory obstacles to generic competition across the full range of FDA-approved drugs through the Drug Competition Action Plan.